This interview with Stephan Weidinger, MD, PhD, at AAD 2026 highlights new data on lebrikizumab
Stephan Weidinger, MD, PhD
Advertisement
Stephan Weidinger, MD, PhD, professor and chair for Dermatology at the Christian-Albrechts-University and director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein.
Articles by Stephan Weidinger, MD, PhD
In this set of interviews, 6 leaders in the field of dermatology highlight their experiences at the 2025 EADV Congress.
Weidinger discusses results from a pair of late-breaking presentations on temtokibart in atopic dermatitis from EADV 2025.
Advertisement
Latest Updated Articles
Expert Perspectives: Top News in Dermatology from EADV Congress 2025September 30th 2025
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
3
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
4
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
5